Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT02822118 | Therapeutic Effect of Chang'an I Recipe on Irritable Bowel Syndrome With Diarrhea | PHASE1 | COMPLETED | 216 | — | — | Jan 1, 2013 | May 1, 2016 | Sep 5, 2016 | 5 | China |
Score less than 75 points was considered as in remission, 75\~175 as mild, 175\~300 as moderate, and over 300 as severe.
| Arm | Type | Description |
|---|---|---|
| Chang'an I Recipe | EXPERIMENTAL | Patients in this group were administered the Chang'an I Recipe for 8 weeks. |
| Placebo | PLACEBO_COMPARATOR | Patients in this group were administered the placebo for 8 weeks. |
| Name | Type | Description |
|---|---|---|
| Chang'an I Recipe | DRUG | Patients in this group were administered the Chang'an I Recipe, 150ml/bag, 3 times/day for 8 weeks. |
| Placebo | DRUG | Patients in this group were administered the placebo, 150ml/bag, times/day for 8 weeks. |
Inclusion Criteria: * Patients meeting the diagnostic criteria of Western medicine for IBS-D; * aged 18-70 years old; with a baseline IBS-SSS score over 75 points; * voluntarily signed the informed consent; * local resident who could ensure follow-ups, with basic reading ability. Exclusion Criteri...